149 related articles for article (PubMed ID: 12674493)
1. Trends in prescribing ACE-inhibitors for congestive heart failure in elderly people.
Antonelli Incalzi R; Pedone C; Pahor M; Onder G; Carbonin PU;
Aging Clin Exp Res; 2002 Dec; 14(6):516-21. PubMed ID: 12674493
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacist outreach program directed at physicians treating congestive heart failure.
Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
[TBL] [Abstract][Full Text] [Related]
4. Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature.
Litaker JR; Chou JY
Clin Ther; 2003 Jul; 25(7):1918-35. PubMed ID: 12946542
[TBL] [Abstract][Full Text] [Related]
5. Prescribing and emergency admissions for heart failure in greater Glasgow.
Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
[TBL] [Abstract][Full Text] [Related]
6. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
[TBL] [Abstract][Full Text] [Related]
7. Managing congestive heart failure.
Jessup M
Geriatrics; 1988 Nov; 43(11):35-9, 42. PubMed ID: 3181762
[TBL] [Abstract][Full Text] [Related]
8. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
9. Underutilisation of ACE inhibitors in patients with congestive heart failure.
Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
[TBL] [Abstract][Full Text] [Related]
10. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
Michaels AD; Maynard C; Every NR; Barron HV
Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995.
Rich MW; Brooks K; Luther P
Am Heart J; 1998 Mar; 135(3):367-72. PubMed ID: 9506320
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP).
Mehta SS; Wilcox CS; Schulman KA
Am J Hypertens; 1999 Apr; 12(4 Pt 1):333-40. PubMed ID: 10232492
[TBL] [Abstract][Full Text] [Related]
13. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
[TBL] [Abstract][Full Text] [Related]
14. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
Krumholz HM; Vaccarino V; Ellerbeck EF; Kiefe C; Hennen J; Kresowik TF; Gold JA; Jencks SF; Radford MJ
Am J Cardiol; 1997 Mar; 79(5):581-6. PubMed ID: 9068512
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibitors in congestive heart failure.
Kantner TR
J Fam Pract; 1992 Sep; 35(3):305-14. PubMed ID: 1517728
[TBL] [Abstract][Full Text] [Related]
16. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study.
Echemann M; Zannad F; Briançon S; Juillière Y; Mertès PM; Virion JM; Villemot JP
Am Heart J; 2000 Apr; 139(4):624-31. PubMed ID: 10740143
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of heart failure: an analysis of actual treatment practices in outpatients in Switzerland. The Swiss "IMPROVEMENT of HF" Group].
Muntwyler J; Follath F
Schweiz Med Wochenschr; 2000 Aug; 130(34):1192-8. PubMed ID: 11013922
[TBL] [Abstract][Full Text] [Related]
18. Prescribing trends for management of congestive heart failure from 2002 to 2004.
Crawford T; Segars LW; Rasu RS
Res Social Adm Pharm; 2013; 9(4):482-9. PubMed ID: 21272523
[TBL] [Abstract][Full Text] [Related]
19. Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study.
Maison P; Cunin P; Hemery F; Fric F; Elie N; Del'volgo A; Dubois-Randé JL; Hittinger L; Macquin-Mavier I
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):445-51. PubMed ID: 15940531
[TBL] [Abstract][Full Text] [Related]
20. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
